On November 2, 2020, the Drug Enforcement Administration (DEA) published notice of a new Proposed Rule, “Suspicious Orders of Controlled Substances,” to “clarify the procedures a registrant must follow for orders received under suspicious... Read More
Blogs & Articles | Healthcare | Healthcare Law | Pharmacy Law | White Collar Defense and Government Investigation

False Claims Act (“FCA”) cases brought by the Department of Justice (“DOJ”) returned only $2.2 billion in recovered funds in 2020, down from $3.0 billion in 2019 and $2.9 billion in 2018, making 2020’s FCA recovery amount the lowest since... Read More
Blogs & Articles | Healthcare | Healthcare Law | White Collar Defense and Government Investigation

We are excited to welcome our newest Partner, Anthony Mahajan, Esq., who joins the Firm’s Litigation and Regulatory Departments and will serve as the Chair of our White Collar Defense & Government Investigations Practice. Anthony brings to... Read More
Blogs & Articles | White Collar Defense and Government Investigation

In November 2020, the U.S. Department of Health & Human Services, Office of Inspector General (the “OIG”) issued a Special Fraud Alert to highlight the fraud and abuse risks associated with pharmaceutical and medical device company speaker... Read More
Blogs & Articles | Professional Board Actions | Professional Practice Representation | White Collar Defense and Government Investigation

At a court hearing on November 24, 2020, a bankruptcy judge approved a settlement entered in late October between Purdue Pharma L.P. (“Purdue”) and the Department of Justice (“DOJ”), under which Purdue Pharma L.P. plead guilty in New Jersey... Read More
Pain Management Compliance | White Collar Defense and Government Investigation

Frier Levitt Co-Founding Partner Daniel B. Frier recently summarized a variety of ways in which providers can become ensnarled in fraudulent schemes disguised as legitimate business models.  Since the publication of that article, a significant... Read More
Federal and State Fraud and Abuse Counseling | Healthcare | Hospitals and Healthcare Systems | In-house Counsel Legal Support Services | Professional Board Actions | Regulatory Compliance, including FDA, DEA and HIPAA | White Collar Defense and Government Investigation

The Office of the Inspector General for Health and Human Services (OIG) issued a comprehensive review of the effectiveness of the Food and Drug Administration’s (FDA) Risk Evaluation and Mitigation Strategy (REMS) for certain opioid-based drugs.... Read More
Chain Pharmacies | Life Sciences | Manufacturers | White Collar Defense and Government Investigation

On September 9, 2020, the Justice Department (DOJ) announced an acute care hospital located in West Virginia (Hospital) agreed to pay the United States a total of Five-Hundred Million Dollars to resolve claims that it violated the Federal False... Read More
Blogs & Articles | Healthcare | Healthcare Practice Compliance | White Collar Criminal Defense & Government Investigations | White Collar Defense and Government Investigation